Lung Alliance Netherlands

Long Alliantie Nederland is a Dutch patient alliance representing people affected by lung disease, including severe COPD. Its psychedelic relevance is specific rather than generalized, because it is an active patient partner in the EU-funded PsyPal trial on psilocybin-assisted therapy in palliative care.

That role makes the stakeholder more useful than a passive consortium mention. The alliance has publicly promoted the PsyPal launch, later recruitment opportunities, and the first patient selection, giving Blossom a clear Netherlands-based example of disease-community involvement in psychedelic implementation research.